We are live on
!
Find out more
BII
Bainco International Investors Portfolio holdings
AUM
$873M
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+30.2%
3 Year Est. Return
+227.64%
5 Year Est. Return
+395.03%
10 Year Est. Return
–
AUM
$835M
AUM Growth
+$171M
(+26%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
16.79%
Top 10 Holdings %
Top 10 Hldgs %
48.83%
Holding
96
New
7
Increased
54
Reduced
15
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.4M |
| 2 |
RTN
Raytheon Company
RTN
|
+$3.86M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.44M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.17M |
| 5 |
UroGen Pharma
URGN
|
+$1.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$2.89M |
| 2 |
GE Aerospace
GE
|
+$2.12M |
| 3 |
Corpay
CPAY
|
+$659K |
| 4 |
IBDH
iShares iBonds Dec 2018 Term Corporate ETF
IBDH
|
+$232K |
| 5 |
STRP
Straight Path Communications Inc.
STRP
|
+$225K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.36% |
| 2 | Communication Services | 8.67% |
| 3 | Technology | 8.05% |
| 4 | Financials | 7.95% |
| 5 | Consumer Discretionary | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $253K | 0.03% |
5,000
| – | – |
|
77
iShares Russell 1000 Growth ETF
IWF
$127B
| $233K | 0.03% |
7,456
| – | – |
|
78
Duke Energy
DUK
$94.5B
| $227K | 0.03% |
2,706
-100
| -4% | -$8.56K |
|
79
Pfizer
PFE
$154B
| $226K | 0.03% |
6,663
-2,952
| -31% | -$94.9K |
|
|
CARB
80
DELISTED
Carbonite Inc
CARB
| $220K | 0.03% |
10,000
| – | – |
|
81
Alibaba
BABA
$317B
| $215K | 0.03% |
+1,245
| New | +$202K |
|
82
Philip Morris
PM
$290B
| $212K | 0.03% |
1,910
| – | – |
|
|
OBE
83
Obsidian Energy
OBE
$699M
| $11K | ﹤0.01% |
1,429
| – | – |
|
|
BSTG
84
DELISTED
Biostage, Inc. Common Stock
BSTG
| $4K | ﹤0.01% |
14,200
+2,000
| +16% | +$801 |
|
85
Vale
VALE
$63.4B
| – | – |
-10,000
| Closed | -$88K |
|
|
STRP
86
DELISTED
Straight Path Communications Inc.
STRP
| – | – |
-1,250
| Closed | -$225K |
|
|
KITE
87
DELISTED
Kite Pharma, Inc.
KITE
| – | – |
-27,840
| Closed | -$2.89M |
|
Similar funds
HCMNY
HCM
DBC
LCM
DK
AVAX
IVA
SWM
Bainco International Investors's Q3 2017 Portfolio in Review
As of Q3 2017, Bainco International Investors held 96 positions worth $835M, up 26% from $665M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bainco International Investors deployed $140M of net new capital in Q3 2017, opening 7 new positions and adding to 54 existing holdings. Its largest new stake was Raytheon Company: 21,895 shares worth $4.08M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was GE Aerospace, an estimated $2.12M trimmed.
- Bainco International Investors's largest Q3 2017 buy was Raytheon Company: 21,895 shares worth $4.08M.
- Bainco International Investors added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $45.4M increase.
- Bainco International Investors's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $2.12M.
- Bainco International Investors fully exited Kite Pharma, Inc. in Q3 2017, selling an estimated $2.89M.
- Bainco International Investors's ten largest holdings make up 49% of its $835M portfolio in Q3 2017.
- Bainco International Investors opened 7 new positions and closed 6 in Q3 2017.
- Bainco International Investors's portfolio value rose 26% quarter-over-quarter to $835M.
Based on Bainco International Investors's 13F filing for Q3 2017, filed 27 Oct 2017.